SCHEMBL8435129

SCHEMBL8435129

O=C(O)CC(=O)c1cc(Cl)c(F)c(F)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC5 P28715 7/20 0.38
FEN1 P39748 7/20 0.38
GPR17 Q13304 1/20 0.35
POLB P06746 1/20 0.34
KAT6A Q92794 2/20 0.34
HPGD P15428 3/20 0.33
USP2 O75604 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
PTPN1 P18031 1/20 0.33
FABP4 P15090 1/20 0.32
EIF4A3 P38919 1/20 0.32
NPC1 O15118 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
ALOX15 P16050 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30417758 1.00 ERCC5 (0.38) ERCC5FEN1GPR17POLBKAT6A
SCHEMBL8437425 0.87 GPR17 (0.40) ERCC5FEN1GPR17POLBKAT6A
SCHEMBL30194898 0.81 PTPN1 (0.38) ERCC5FEN1PTPN1MAPK1SMN1; SMN2
SCHEMBL1187294 0.81 PTPN1 (0.38) ERCC5FEN1PTPN1MAPK1SMN1; SMN2
SCHEMBL8683261 0.78 KEAP1 (0.44) POLBHPGDUSP2MEN1KMT2A
SCHEMBL30181088 0.77 MEN1 (0.42) HPGDMEN1KMT2ALMNATP53
SCHEMBL7011856 0.77 MEN1 (0.42) HPGDMEN1KMT2ALMNATP53
SCHEMBL8433214 0.76 KEAP1 (0.37) ERCC5FEN1GPR17POLBHPGD
SCHEMBL7187870 0.76 HPGD (0.39) POLBHPGDUSP2MEN1KMT2A
SCHEMBL8727081 0.76 ALDH1A1 (0.41) POLBHPGDUSP2LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116157392-A Compounds targeting RNA binding proteins or RNA modification proteins 雷多纳治疗公司 2023-05-23 CN disclosed
US-5969141-A Intermediates for 7-amino-1-cyclopropyl-6,8-dihalogeno-1,4-dihydro-4-oxo-3-quinolinecarbox ylic acid antibacterial agents BAYER AKTIENGESELLSCHAFT (DE) 1999-10-19 US disclosed
US-5777181-A 2, 4, 5-trihalogeno- and 2, 3, 4, 5-tetrahalogenobenzene derivatives BAYER AKTIENGESELLSCHAFT (DE) 1998-07-07 US disclosed
US-5571812-A TREATMENT OF INFECTIONS OF GRAMNEGATIVE AND GRAMPOSITIVE BACTERIA BAYER AKTIENGESELLSCHAFT (DE) 1996-11-05 US disclosed
US-5565614-A FLUORINATION BAYER AKTIENGESELLSCHAFT (DE) 1996-10-15 US disclosed
US-5530158-A CHEMICAL INTERMEDIATE FOR ANTIBACTERIALS BAYER AKTIENGESELLSCHAFT (DE) 1996-06-25 US disclosed
US-5468861-A Bactericides BAYER AKTIENGESELLSCHAFT (DE) 1995-11-21 US disclosed
US-5362909-A Two stage fluorination BAYER AKTIENGESELLSCHAFT (DE) 1994-11-08 US disclosed
US-5200548-A Intermediates for bactericides BAYER AKTIENGESELLSCHAFT (DE) 1993-04-06 US disclosed
US-5072038-A Chemical intermediates for bactericides BAYER AKTIENGESELLSCHAFT (DE) 1991-12-10 US disclosed
US-4703047-A 1-Cyclopropyl-1,4-dihydro-4-oxo-7-(4-(2-oxo-1,3-dioxol-4-yl-methyl)-1-piperazinyl)-3-quinolinecarboxylic acid antibacterial agents BAYER AKTIENGESELLSCHAFT (DE) 1987-10-27 US disclosed